Inactive Instrument

Medifirst Solutions, Inc

Equities

MFST

US58471B2025

Advanced Medical Equipment & Technology

Medifirst Solutions, Inc Reports Earnings Results for the First Quarter Ended March 31, 2019

May 20, 2019 at 02:52 pm EDT

Medifirst Solutions Inc. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced total revenue was USD 26,400 compared to USD 4,550 a year ago. Operating loss was USD 250,842 compared to USD 136,923 a year ago. Net loss was USD 808,404 compared to USD 294,569 a year ago. Basic loss per share from continuing operations was USD 0.17 compared to USD 0.28 a year ago.

Latest news about Medifirst Solutions, Inc

Medifirst Solutions, Inc. Announces CEO Changes	21-07-26	CI
Medifirst Solutions, Inc Announces Executive Changes	21-06-24	CI
Medifirst Solutions, Inc Announces Clinical Study for Breast Cancer Diagnostic Medical Device	21-02-22	CI
Medifirst Solutions, Inc Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-19	CI
Medifirst Solutions, Inc announced that it has received $0.038 million in funding from PowerUp Lending Group, Ltd.	19-08-27	CI
Medifirst Solutions, Inc Announces Setting Up of Clinical Trial for the Treatment in Reducing Oral Mucositis	19-08-22	CI
Medifirst Solutions, Inc announced that it has received $0.045 million in funding from PowerUp Lending Group, Ltd.	19-08-20	CI
Medifirst Solutions, Inc Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-19	CI
Medifirst Solutions Provides Company Update for Its Time Machine Laser and CBD Division	19-08-07	CI
Medifirst Solutions, Inc announced that it has received $0.043 million in funding from PowerUp Lending Group, Ltd.	19-06-13	CI
Medifirst Solutions, Inc announced that it expects to receive $0.043 million in funding from PowerUp Lending Group, Ltd.	19-06-10	CI
Medifirst Solutions, Inc. Gets Approval for Merchant Account for Hemp and CBD Products	19-06-06	CI
Medifirst Solutions, Inc Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-20	CI
Medifirst Solutions, Inc announced that it has received $0.058 million in funding	19-04-28	CI
Medifirst Solutions, Inc announced that it expects to receive $0.058 million in funding	19-04-25	CI
Medifirst Solutions, Inc Reports Earnings Results for the Full Year Ended December 31, 2018	19-04-15	CI
Medifirst Solutions, Inc announced that it has received $0.043 million in funding from PowerUp Lending Group, Ltd.	19-03-21	CI
Medifirst Solutions, Inc Completes Distribution Agreement with Dimex	19-03-21	CI
Medifirst Solutions, Inc announced that it has received $0.0535 million in funding from GS Capital Partners LLC	19-02-19	CI
Medifirst Solutions, Inc announced that it has received $0.038 million in funding from PowerUp Lending Group, Ltd.	19-02-05	CI
Medifirst Solutions, Inc announced that it expects to receive $0.038 million in funding from PowerUp Lending Group, Ltd.	19-02-03	CI
Medifirst Solutions, Inc announced that it has received $0.043 million in funding from PowerUp Lending Group, Ltd.	19-01-27	CI
Medifirst Solutions, Inc announced that it expects to receive $0.043 million in funding from PowerUp Lending Group, Ltd.	19-01-23	CI
Medifirst Solutions, Inc Introduces Sanjay Gupta as Partner in its New Cannabidiol Division	18-11-28	CI
Medifirst Solutions, Inc Announces Completion of an Agreement with Dr. Gupta Pharma LLC to Distribute a Line of Premium CBD Oils	18-11-21	CI

Chart Medifirst Solutions, Inc

Duration

Period

More charts

Company Profile

Medifirst Solutions, Inc. is a development-stage company. The Company is engaged in developing medical devices. The Company, under a manufacturing agreement, produces its hand-held mobile laser system known as The Time Machine Program. Through its subsidiary Medical Laser Manufacturer, Inc., the Company has entered into a Product and Know-How License Agreement (the License Agreement) with Laser Lab Corp to license the use of various properties in connection with seeking regulatory approval for and marketing, distributing and selling The Time Machine Series Lasers (TTM Series). In addition to the license granted to the Company, the License Agreement provides for an option to license other fields of use of the infrared laser in the TTM Series, as well as other wavelengths and colors, allowing the Company to develop a range of product offerings. The Time Machine Infrared Laser 810/830-nanometer (nm) operates in continuous wave mode set at a fixed frequency.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+8.07%	219B
DANAHER CORPORATION	+6.59%	183B
INTUITIVE SURGICAL, INC.	+11.26%	133B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
SIEMENS HEALTHINEERS AG	+0.65%	63.06B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	48.2B
AGILENT TECHNOLOGIES, INC.	-0.93%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.35B

Other Advanced Medical Equipment & Technology